Vical Company Profile (NASDAQ:VICL)

About Vical

Vical logoVical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, or partnered development programs in the areas of infectious disease including Phase III clinical trial of ASP0113 for prevention of cytomegalovirus (CMV) reactivation in stem cell transplant recipients and Phase II clinical trial of ASP0113 for prevention of CMV infection in kidney transplant recipients; Phase I/II clinical trial of its therapeutic genital herpes vaccine, designed to reduce viral shedding and genital herpes lesions in herpes simplex virus type 2 (HSV-2) infected patients; an ongoing Phase I program of VL-2397 for invasive fungal infections, and completed preclinical program, with an allowed investigational new drug application (IND) using its CyMVectin prophylactic vaccine formulated with its Vaxfectin adjuvant.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: VICL
  • CUSIP: 92560210
Key Metrics:
  • Previous Close: $3.99
  • 50 Day Moving Average: $4.28
  • 200 Day Moving Average: $4.05
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -66.50
  • P/E Growth: 0.00
  • Market Cap: $36.73M
  • Outstanding Shares: 9,206,000
  • Beta: 2.1
Additional Links:
Companies Related to Vical:

Analyst Ratings

Consensus Ratings for Vical (NASDAQ:VICL) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Vical (NASDAQ:VICL)
DateFirmActionRatingPrice TargetDetails
7/19/2016HC WainwrightReiterated RatingBuyView Rating Details
6/23/2015Roth CapitalDowngradeBuy -> Neutral$4.65 -> $1.65View Rating Details
(Data available from 8/27/2014 forward)


Earnings History for Vical (NASDAQ:VICL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2016Q216($0.28)($0.14)$4.50 million$4.10 millionViewN/AView Earnings Details
5/9/2016Q116($0.04)($0.03)$6.88 million$4.60 millionViewN/AView Earnings Details
3/14/2016Q415($0.02)($0.03)$4.82 million$6.81 millionViewListenView Earnings Details
7/30/2015Q215($0.06)($0.03)$3.80 million$4.20 millionViewListenView Earnings Details
5/8/2015Q115($0.05)($0.04)$2.50 million$4.90 millionViewN/AView Earnings Details
2/26/2015Q414($0.05)($0.05)$4.82 millionViewN/AView Earnings Details
10/30/2014Q314($0.05)($0.05)$2.50 million$3.40 millionViewN/AView Earnings Details
7/31/2014Q214($0.05)($0.05)$1.90 million$4.50 millionViewN/AView Earnings Details
5/1/2014Q114($0.05)($0.04)$1.60 million$2.40 millionViewN/AView Earnings Details
2/11/2014Q413($0.09)($0.03)$1.54 million$3.15 millionViewN/AView Earnings Details
10/31/2013Q313($0.10)($0.11)$1.82 million$1.50 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.11)($0.11)$1.70 million$3.00 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.11)($0.11)$2.02 million$1.60 millionViewN/AView Earnings Details
2/6/2013Q4 2012($0.10)($0.09)$1.64 million$2.32 millionViewN/AView Earnings Details
11/7/2012Q312($0.09)($0.09)$1.47 million$2.20 millionViewN/AView Earnings Details
8/1/2012($0.09)($0.09)ViewN/AView Earnings Details
11/1/2011$0.11$0.22ViewN/AView Earnings Details
8/3/2011($0.12)($0.12)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Vical (NASDAQ:VICL)
Current Year EPS Consensus Estimate: $-0.82 EPS
Next Year EPS Consensus Estimate: $-0.06 EPS


Dividend History for Vical (NASDAQ:VICL)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Vical (NASDAQ:VICL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/11/2016Lawrence Russell SmithVPSell54$4.46$240.84View SEC Filing  
6/14/2016Robert C MertonDirectorBuy9,000$4.34$39,060.00View SEC Filing  
6/9/2016Vijay B SamantCEOBuy15,700$4.72$74,104.00View SEC Filing  
6/6/2016R Gordon DouglasDirectorBuy10,078$4.41$44,443.98View SEC Filing  
6/3/2016Gary A LyonsDirectorBuy7,078$4.39$31,072.42View SEC Filing  
3/15/2016Lawrence Russell SmithVPSell8,750$0.41$3,587.50View SEC Filing  
3/3/2016Vijay B SamantCEOSell37,500$0.36$13,500.00View SEC Filing  
2/19/2016Anthony Alan RamosCAOSell7,500$0.33$2,475.00View SEC Filing  
1/25/2016Anthony Alan RamosCAOSell193$0.35$67.55View SEC Filing  
1/12/2016Vijay B. SamantCEOSell59,737$0.35$20,907.95View SEC Filing  
1/11/2016Lawrence Russell SmithVPSell974$0.36$350.64View SEC Filing  
1/11/2016Vijay B. SamantCEOSell48,535$0.35$16,987.25View SEC Filing  
1/7/2016Vijay B SamantCEOSell75,000$0.36$27,000.00View SEC Filing  
10/12/2015Lawrence Russell SmithVPSell974$0.43$418.82View SEC Filing  
10/12/2015Vijay B SamantCEOSell4,738$0.41$1,942.58View SEC Filing  
7/13/2015Igor BilinskySVPSell1,258$0.70$880.60View SEC Filing  
7/13/2015Lawrence Russell SmithVPSell974$0.70$681.80View SEC Filing  
7/13/2015Vijay B SamantCEOSell4,737$0.70$3,315.90View SEC Filing  
4/13/2015Igor BilinskySVPSell1,257$0.93$1,169.01View SEC Filing  
4/13/2015Vijay B SamantCEOSell4,738$0.93$4,406.34View SEC Filing  
3/30/2015Vijay B SamantCEOSell55,000$0.91$50,050.00View SEC Filing  
1/13/2015Vijay B SamantCEOSell4,737$1.12$5,305.44View SEC Filing  
1/12/2015Igor BilinskySVPSell1,335$1.16$1,548.60View SEC Filing  
1/12/2015Lawrence Russell SmithVPSell1,912$1.16$2,217.92View SEC Filing  
10/13/2014Igor BilinskySVPSell1,335$1.08$1,441.80View SEC Filing  
10/13/2014Lawrence Russell SmithVPSell1,912$1.08$2,064.96View SEC Filing  
10/13/2014Vijay B SamantCEOSell4,738$1.13$5,353.94View SEC Filing  
8/26/2014Anthony Alan RamosCAOSell12,500$1.25$15,625.00View SEC Filing  
7/14/2014Vijay B SamantCEOSell4,737$1.17$5,542.29View SEC Filing  
7/11/2014Lawrence Russell SmithVPSell1,912$1.16$2,217.92View SEC Filing  
4/14/2014Vijay SamantCEOSell4,738$1.16$5,496.08View SEC Filing  
4/11/2014Lawrence Russell SmithVPSell1,912$1.21$2,313.52View SEC Filing  
1/10/2014Anthony Alan RamosCAOBuy70,000$1.42$99,400.00View SEC Filing  
1/10/2014Igor BilinskyVPBuy90,000$1.42$127,800.00View SEC Filing  
1/10/2014Vijay SamantCEOBuy330,000$1.42$468,600.00View SEC Filing  
9/12/2013James R SingerMajor ShareholderSell200,000$1.29$258,000.00View SEC Filing  
9/11/2013James R SingerMajor ShareholderSell300,000$1.30$390,000.00View SEC Filing  
9/10/2013James R SingerMajor ShareholderSell200,000$1.23$246,000.00View SEC Filing  
9/9/2013James R SingerMajor ShareholderSell200,000$1.22$244,000.00View SEC Filing  
9/4/2013James Singermajor shareholderSell466,000$1.24$577,840.00View SEC Filing  
8/30/2013James Singermajor shareholderSell84,000$1.31$110,040.00View SEC Filing  
8/29/2013James Singermajor shareholderSell150,000$1.30$195,000.00View SEC Filing  
8/28/2013James Singermajor shareholderSell200,000$1.31$262,000.00View SEC Filing  
8/26/2013Anthony Alan RamosCAOBuy25,000$0.01$250.00View SEC Filing  
5/23/2013Robert C MertonDirectorBuy5,953$0.01$59.53View SEC Filing  
1/11/2013Alain P Phd RollandVPBuy22,092$0.01$220.92View SEC Filing  
1/11/2013Jill Marie BroadfootCFOBuy27,060$0.01$270.60View SEC Filing  
1/11/2013Vijay B SamantCEOBuy84,600$0.01$846.00View SEC Filing  
10/15/2012George J MorrowDirectorBuy6,394$0.01$63.94View SEC Filing  
9/24/2012James R SingerMajor ShareholderBuy154,333$3.99$615,788.67View SEC Filing  
8/31/2012James R SingerMajor ShareholderBuy310,000$3.51$1,088,100.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Vical (NASDAQ:VICL)
DateHeadline logoVical, Inc. :VICL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:VICL) - August 11 at 11:35 AM logoVical Incorporated: Vical Reports Second Quarter 2016 Financial Results (NASDAQ:VICL) - August 10 at 11:22 AM logoVical's (VICL) CEO Vijay Samant on Q2 2016 Results - Earnings Call Transcript (NASDAQ:VICL) - August 10 at 11:22 AM logoVical Reports Second Quarter 2016 Financial Results - GlobeNewswire (press release) (NASDAQ:VICL) - August 9 at 11:35 AM logoVical reports 2Q loss (NASDAQ:VICL) - August 9 at 11:35 AM logoInvestor Calendar Invites You to the Vical Second Quarter 2016 Earnings Webcast Live on Tuesday, August 9, 2016 (NASDAQ:VICL) - August 8 at 8:19 PM logoVICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Fin (NASDAQ:VICL) - August 3 at 11:29 AM logoVical Incorporated: Vical Announces News Release and Conference Call Schedule for Second Quarter 2016 Financial Results (NASDAQ:VICL) - August 2 at 8:31 PM logoVical Announces News Release and Conference Call Schedule for Second Quarter 2016 Financial Results (NASDAQ:VICL) - August 2 at 7:52 AM logoVical Announces $7.8 Million Equity Investment by Partner, AnGes MG (NASDAQ:VICL) - August 1 at 6:41 AM logo6:31 am Vical confirms $7.8 mln investment from AnGes, MG (NASDAQ:VICL) - August 1 at 6:31 AM logoETF’s with exposure to Vical, Inc. : July 26, 2016 (NASDAQ:VICL) - July 26 at 12:08 PM logoLeading, Losing Stocks in Manufacturing Sector Pre Market (NASDAQ:VICL) - July 25 at 7:45 AM
News IconReasons for Lawrence Smith's Shares Sale of Vical Incorporated (NASDAQ:VICL)'s Stock - Press Telegraph (NASDAQ:VICL) - July 13 at 8:27 PM
News IconHere is What Institutional Investors Think About Vical Inc (NASDAQ:VICL) - Consumer Eagle (NASDAQ:VICL) - July 12 at 12:29 PM logoNew Study: Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review (NASDAQ:VICL) - June 30 at 10:49 AM logoNext Weeks Broker Price Targets For Vical Incorporated (VICL) - Fiscal Standard (NASDAQ:VICL) - June 27 at 7:31 AM logoVical Incorporated (VICL) Current Analyst Ratings - Fiscal Standard (NASDAQ:VICL) - June 24 at 8:06 PM logoVical (VICL) Reports Phase I/II Data on Genital Herpes Vaccine (NASDAQ:VICL) - June 21 at 10:12 AM logoThis Weeks Broker Views For Vical Incorporated (VICL) - Fiscal Standard (NASDAQ:VICL) - June 21 at 7:22 AM logoVical’s Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent Vaccine Imparts Reduction in Genital Herpes Lesions Durable to 9 Months (NASDAQ:VICL) - June 20 at 11:39 AM logoVical to Present HSV-2 Phase 1/2 Data at June ASM Microbe/ICAAC 2016 Conference (NASDAQ:VICL) - June 13 at 6:49 AM
News IconLyons Gary A, Director of Vical Incorporated (NASDAQ:VICL) buys 7,078 shares (NASDAQ:VICL) - June 7 at 8:24 PM logoVical (VICL) Plans Presentation of VL-2397 Data at BIO International Convention (NASDAQ:VICL) - June 2 at 11:25 AM logoVical Provides VL-2397 Updates at BIO International Convention (NASDAQ:VICL) - May 31 at 6:42 AM logo5 Gainers And Losers In The Pre-Market Today (NASDAQ:VICL) - May 27 at 11:16 AM logoVICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Ch (NASDAQ:VICL) - May 25 at 9:01 AM
News IconBroker Outlook For The Week Ahead Vical Incorporated (VICL) - Share Trading News (NASDAQ:VICL) - May 24 at 2:00 PM logoHealthcare Movers to Observe: Grifols, S.A. (NASDAQ:GRFS) , Vical Incorporated (NASDAQ:VICL) - Is stories (NASDAQ:VICL) - May 24 at 2:00 PM logoTraders Spotlight: Vical Incorporated (NASDAQ:VICL) , Amedica Corporation (NASDAQ:AMDA) - Street Updates (NASDAQ:VICL) - May 20 at 1:47 PM logoVical, Inc. :VICL-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:VICL) - May 18 at 2:00 PM logoBuy Recommendations Count For Vical Incorporated (NASDAQ:VICL) At 0 - Stocks Daily (NASDAQ:VICL) - May 17 at 2:20 PM
News IconNext Weeks Broker Price Targets For Vical Incorporated (VICL) - Share Trading News (NASDAQ:VICL) - May 17 at 2:20 PM logoRevenue Update on Vical Incorporated(NASDAQ:VICL) - Trade Calls (NASDAQ:VICL) - May 17 at 2:20 PM
News IconEarnings per Share Report: Vical Incorporated (NASDAQ:VICL) - News Oracle (NASDAQ:VICL) - May 12 at 8:06 AM
News IconEarnings in Focus: Vical Incorporated (NASDAQ:VICL) - News Oracle (NASDAQ:VICL) - May 12 at 8:06 AM
News IconAfter Last Week What Do Analysts Think Of Vical Incorporated (VICL) - Share Trading News (NASDAQ:VICL) - May 11 at 7:22 AM logoVical's (VICL) CEO Vijay Samant on Q1 2016 Results - Earnings Call Transcript (NASDAQ:VICL) - May 10 at 7:43 AM logoQ1 2016 Vical Inc Earnings Release - Before Market Open (NASDAQ:VICL) - May 9 at 7:07 AM logoVical Reports First Quarter 2016 Financial Results (NASDAQ:VICL) - May 9 at 6:56 AM logoVical reports 1Q loss (NASDAQ:VICL) - May 9 at 6:36 AM logoInvestor Calendar Invites You to the Vical First Quarter 2016 Earnings Webcast Live on Monday, May 9, 2016 (NASDAQ:VICL) - May 6 at 4:05 PM
News IconVical Incorporated (VICL) Updated Broker Price Targets - Share Trading News (NASDAQ:VICL) - May 6 at 7:51 AM logoVical Announces News Release and Conference Call Schedule for First Quarter 2016 Financial Results (NASDAQ:VICL) - May 2 at 6:50 AM
News IconBroker Roundup For Vical Incorporated (VICL) - Share Trading News (NASDAQ:VICL) - April 29 at 8:14 AM
News IconLatest Analyst Ratings For Vical Incorporated (VICL) - Share Trading News (NASDAQ:VICL) - April 22 at 8:33 AM logoVical Incorporated (NASDAQ:VICL) Reported Comprehensive Income Of $0.04 - Investor Newswire (NASDAQ:VICL) - April 20 at 9:06 AM logoCan Shares Of Vical Incorporated (NASDAQ:VICL) Hit $2.5? - Investor Newswire (NASDAQ:VICL) - April 12 at 11:47 AM logoVical Incorporated (NASDAQ:VICL) ABR At 2 - Investor Newswire (NASDAQ:VICL) - April 12 at 11:47 AM logoVical Incorporated (NASDAQ:VICL)'s 52-Week Price Target At $2.5000 - Investor Newswire (NASDAQ:VICL) - April 12 at 11:47 AM


Vical (NASDAQ:VICL) Chart for Saturday, August, 27, 2016

Last Updated on 8/27/2016 by Staff